Samsung Biologics Pays $280M to Secure First US Manufacturing Site

URLSamsung Biologics Pays $280M to Secure First US Ma
Sourceconnect cre
Date Published12/22/2025
Author NameJasmine Kilman

Additional Reshoring Information:

Company/Division name Samsung Electronics America
Parent companySamsung Biologics
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):500
Year reshoring announced:2025
Capital investment ($):280
City reshored to:Rockville
State(s) reshored to:MD
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredbiopharmaceuticals
What domestic positive factors made reshoring more attractive?Eco-system synergies, Under-utilized capacity
Find Reshoring Articles